US Market for Heart Defect Closure Devices - 2016, New Report Launched
As of August 2015, the FDA had not approved a device for PFO closure. Therefore, device-based patent foramen ovale (PFO) closure procedures are most commonly performed using atrial septal defect (ASD) closure devices being used off-label. Despite the lack of FDA approval, PFO closure remains popular due to the reduced risk of stroke and the reduced frequency of migraines. Over 2.5 million men and women suffer from atrial fibrillation (AF) in the United States. With many AF patients hesitant to...
View full press release